Delivery Order SPE2DB24D8002-SPE2DB25FJNCH
Award Date
2/5/25
Potential Completion Date
2/6/25
Potential Value
$1K
Federal Agency
Defense Logistics Agency
Awardee
Dakota Drug, Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed-price delivery order contract valued at $3,351.99 to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the provision of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. This award is part of Dakota Drug, Inc.'s broader Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, which allows the company to supply a range of pharmaceutical products, medical supplies,...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $1,041.10, is for the delivery of MOUNJARO 10 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a performance period through January 2, 2024. Dakota Drug, Inc. holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA as part of the DLA Troop Support Medical's ECAT...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the supply of the pharmaceutical product MOUNJARO 2.5 MG/0.5 ML PEN 0.5ML. The fixed-price contract has a ceiling value of $6,350.45 and a period of performance through March 10, 2025. Dakota Drug, Inc. is an established federal contractor, holding a large Indefinite Delivery Contract (IDC) with the DLA worth up to $999,999,999.00 to provide a wide range...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the supply of Mounjaro 7.5 mg/0.5 ml pens. The contract has a ceiling value of $1,958.20 and a period of performance through October 28, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Dakota Drug, Inc. and the DLA Troop Support Medical division, valued at $999,999,999.00, to provide a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of MOUNJARO 10 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a ceiling value of $1,188.84 and a period of performance through January 24, 2025. Dakota Drug, Inc. is a key supplier for the DLA Troop Support Medical division, providing a wide range of pharmaceutical products, medical supplies, and...
This federal contract award, valued at $2,694.90, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract is a delivery order for the pharmaceutical product MOUNJARO 12.5 MG/0.5 ML PEN 0.5ML. The contract has an ultimate completion date of August 30, 2024 and is structured as a firm fixed-price agreement. Dakota Drug, Inc. holds a larger Indefinite Delivery Contract (IDC)...
The Defense Logistics Agency (DLA) awarded a $1,828.50 firm fixed-price delivery order contract to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of 4565765799 - MOUNJARO 10 MG/0.5 ML PEN 0.5ML. This contract award, identified as SPE2DB24FJTMQ, has an ultimate completion date of September 9, 2024. Dakota Drug, Inc. is a for-profit subchapter S corporation that specializes in providing pharmaceutical products, medical supplies, and healthcare equipment to the...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $2,500.92 to Dakota Drug, Inc., a self-certified small disadvantaged business, for the provision of MOUNJARO 5 MG/0.5 ML PEN 0.5ML medical supplies. This award is part of Dakota Drug, Inc.'s existing Indefinite Delivery Contract (IDC) SPE2DB24D8001, valued at $999,999,999.00, under the DLA Troop Support Medical's ECAT Generation V Program. The contract has an ultimate completion date of March 11,...
This is a delivery order contract (SPE2DB24D8002/SPE2DB25FJNCT) awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the supply of pharmaceutical products, medical supplies, and healthcare equipment. The contract has a ceiling value of $10,364.55 and a completion date of February 10, 2025. Dakota Drug, Inc. is a key supplier for the DLA Troop Support Medical division, holding a $999,999,999.00 Indefinite Delivery Contract (IDC)...
This federal contract award with ID SPE2DB24D8002|SPE2DB25FJNGU was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $1,188.84 firm fixed-price delivery order is for the pharmaceutical product MOUNJARO 15 MG/0.5 ML PEN 0.5ML. This award is not associated with a set-aside program. Dakota Drug, Inc. is a key supplier to the DLA Troop Support Medical division, holding a significant Indefinite Delivery Contract (IDC) valued at...